Fidelity Investments’s Cumberland Pharmaceuticals CPIX Stock Holding History

Fidelity Investments’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$321	Buy	41 +20	+95%	+$145	﹤0.01%	5419
2026 Q2	$136	Buy	+21	New	+$101	﹤0.01%	5386
2021 Q3	–	Sell	-422	Closed	-$1K	–	4421
2021 Q2	$1K	Hold	422	–	–	﹤0.01%	4012
2021 Q1	$1K	Hold	422	–	–	﹤0.01%	3815
2020 Q4	$1K	Hold	422	–	–	﹤0.01%	3668
2020 Q3	$1K	Hold	422	–	–	﹤0.01%	3539
2020 Q2	$1K	Buy	+422	New	+$1.53K	﹤0.01%	3442

Other funds holding CPIX

Diversified Trust Memphis, Tennessee $4.69B AUM 22.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Lantern Wealth Advisors Melville, New York $232M AUM 16.88% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Capital Advisors Ltd Shaker Heights, Ohio $987M AUM 13.52% 1-Year Est. Return

Fidelity Investments's CPIX Position: Q3 2026 in Review

Fidelity Investments increased its Cumberland Pharmaceuticals (CPIX) stake by 95% in Q3 2026, buying an estimated $145 and bringing the position to 41 shares worth $321. The position accounts for ﹤0.01% of the portfolio, ranked #5419.

Fidelity Investments first reported a position in CPIX in Q2 2020 and has held it in 7 quarters since. The position peaked at $1K in Q2 2021. 11 funds tracked by Wall St. Rank hold CPIX as of Q3 2026.

Fidelity Investments held 41 shares of Cumberland Pharmaceuticals worth $321 as of Q3 2026.
Fidelity Investments bought 20 Cumberland Pharmaceuticals shares in Q3 2026, an estimated $145.
Cumberland Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #5419 holding.
Fidelity Investments first reported a position in Cumberland Pharmaceuticals in Q2 2020 and has held it in 7 quarters since.
Fidelity Investments's Cumberland Pharmaceuticals position peaked at $1K in Q2 2021.
11 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.